Denied Privigen? You Still Have Options.
Privigen is an intravenous immunoglobulin (IVIG) therapy used to treat primary immunodeficiency and chronic immune thrombocytopenia (ITP), and insurance denials happen regularly even when the need is clear. Plans frequently require prior authorization for Privigen, and some insurers push back if they prefer a different IVIG formulation on their formulary. Step therapy requirements — where you must try and fail a different product first — are also common hurdles people face before getting coverage approved.
Option 1: Appeal Your Denial
Your denial is not final. A detailed letter of medical necessity from your doctor explaining your diagnosis, your history, and why Privigen specifically was chosen can be a powerful tool in the appeals process. Ellen can help you draft your appeal letter.
Option 2: Explore Clinical Trials
Clinical research in the immunoglobulin space is active, with ongoing studies for primary immunodeficiency, ITP, and related conditions. A trial may provide access to Privigen or a similar IVIG therapy at no cost to you. You can explore what's currently enrolling near you at ClinicalTrials.gov by searching your condition or "intravenous immunoglobulin."
Option 3: Patient Assistance Programs
CSL Behring, Privigen's manufacturer, offers financial assistance through the CSL Behring Assist program for eligible individuals. The Immune Deficiency Foundation (primaryimmune.org) and the Platelet Disorder Support Association (pdsa.org) offer support resources specifically for people managing these conditions and navigating access challenges.
For a complete guide to Privigen financial assistance — including copay cards, free drug programs, and independent foundations — see our financial assistance page for Privigen.
Ellen can help you figure out your next step. Start with Ellen →
Frequently Asked Questions
Why was Privigen denied?
Privigen is most often denied because prior authorization wasn't submitted or approved before the prescription was filled, because the plan's formulary prefers a different IVIG product, or because step therapy rules require trying another immunoglobulin brand first. Occasionally, denials stem from diagnosis code mismatches — a documentation issue rather than a coverage issue. The reason on your denial letter is your roadmap for the appeal.
Can I get Privigen through a clinical trial?
It's possible, though not guaranteed. Clinical trials in immunology may study Privigen or similar IVIG formulations, and qualified participants typically receive the study medication at no charge. Whether a trial is right for you depends on your diagnosis, your health history, and what trials are currently enrolling. Talk to your doctor about whether this path makes sense, and search ClinicalTrials.gov for current options.
How long does a Privigen appeal take?
Standard internal appeals are typically decided within 30 days. If your situation is medically urgent — your doctor can attest to this — the decision must come within 72 hours. If your internal appeal is denied, you can request an independent external review, which usually resolves within 45 days. Talk to your doctor before making any decisions about your treatment.